[
  {
    "ticker": "NZK",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969962",
    "id": "02969962",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0731",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzx1n3wzfg4.pdf",
    "summary": "<ul>\n<li><strong>Balance Date Change</strong>: Shifts from 31 January to 30 September; next annual report covers 8 months to 30 September 2025.  </li>\n<li><strong>Revised EBITDA Guidance</strong>: $1M\u2013$7M (pro-forma) for shortened 8-month period ending 30 September 2025, reflecting harvest reduction to rebuild biomass.  </li>\n</ul>\n<p><em>Omitted: Operational rationale for balance date change, contact details.</em></p>",
    "usage": {
      "prompt_tokens": 598,
      "completion_tokens": 88,
      "total_tokens": 686,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:42:45.364549"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969959",
    "id": "02969959",
    "pages": 9,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzprrpnq9q0.pdf",
    "summary": "<h3><strong>Capital Raising Announcement Summary</strong></h3>\n<p><strong>Structure:</strong><br />\n- <strong>Placement:</strong> 150,000,000 new shares at NZ$0.10 per share (~A$0.093).  <br />\n- <strong>Share Purchase Plan (SPP):</strong> Up to NZ$50,000 per eligible shareholder (max 50,000,000 shares, price same as Placement).  </p>\n<p><strong>Key Dates:</strong><br />\n- <strong>Placement Issue Date:</strong> 11 July 2025 (conditional on shareholder/regulatory approvals by 11 July).<br />\n- <strong>SPP:</strong><br />\n  - <strong>Offer Open:</strong> 11 July 2025<br />\n  - <strong>Offer Close:</strong> 25 July 2025<br />\n  - <strong>Results/Issue Date:</strong> 1 August 2025.  </p>\n<p><strong>Purpose:</strong><br />\n- Fund growth initiatives, including expanding non-Medicare channels and regaining Medicare coverage.  </p>\n<p><strong>Notes:</strong><br />\n- SPP open only to NZ shareholders initially; possible extension to Australian holders later.<br />\n- No underwriting or lead manager fees disclosed (standard legal/advisory costs apply).</p>",
    "usage": {
      "prompt_tokens": 3078,
      "completion_tokens": 221,
      "total_tokens": 3299,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:42:24.181750"
  },
  {
    "ticker": "TWR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969958",
    "id": "02969958",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzmmx6c4l07.pdf",
    "summary": "<ul>\n<li><strong>Substantial Holding Disclosure</strong>: Forsyth Barr Investment Management (FBIM) now holds a 5.007% stake (17,151,296 shares) in Tower Limited as of 15 July 2025.  </li>\n<li><strong>Transactions</strong>:  </li>\n<li><strong>Sales</strong>: On-market sales of 3,762,959 shares (~$5.35M).  </li>\n<li><strong>Purchases</strong>: On-market purchases of 12,068,660 shares (~$16.44M).  </li>\n<li><strong>Transfers</strong>: Off-market transfers (121,500 out, 400,829 into DIMS).  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified beyond the change in substantial holding.</em></p>",
    "usage": {
      "prompt_tokens": 1081,
      "completion_tokens": 142,
      "total_tokens": 1223,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:43:09.426825"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969961",
    "id": "02969961",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvztybqcyv8w.pdf",
    "summary": "<h3><strong>Capital Raising Announcement Summary</strong></h3>\n<ul>\n<li><strong>Type</strong>: Placement  </li>\n<li><strong>Total securities issued</strong>: 160,728,498 (PEB ordinary shares)  </li>\n<li><strong>Issue price</strong>: NZ$0.10 per share (~A$0.091)  </li>\n<li><strong>Gross proceeds</strong>: NZ$16,072,850 (~A$14.7M)  </li>\n<li><strong>Purpose</strong>: Fund commercial expansion, non-Medicare growth, and Medicare relaunch efforts  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li>Shareholder approval date: <strong>6 August 2025</strong>  </li>\n<li>Proposed issue date: <strong>13 August 2025</strong>  </li>\n<li><strong>Conditions</strong>: Placement completed <strong>30 May 2025</strong>, but allotment pending shareholder approval (obtained regulatory waiver on <strong>12 June 2025</strong>).  </li>\n</ul>\n<p><em>No material underwriting, escrow, or dividend policy changes disclosed.</em></p>",
    "usage": {
      "prompt_tokens": 1703,
      "completion_tokens": 180,
      "total_tokens": 1883,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:42:53.200570"
  },
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969960",
    "id": "02969960",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250717",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lvzrvk2pblfn.pdf",
    "summary": "<p><strong>Capital Raising Announcement:</strong><br />\n- <strong>Structure:</strong> Placement (in lieu of Directors' fees)<br />\n- <strong>Total securities issued:</strong> 1,930,000 ordinary shares (PEB)<br />\n- <strong>Issue price:</strong> NZD 0.10 per share (~AUD 0.091, total ~AUD 176,255)<br />\n- <strong>Key condition:</strong> Shareholder approval at ASM on <strong>6 August 2025</strong><br />\n- <strong>Issue date:</strong> <strong>13 August 2025</strong><br />\n- <strong>Purpose:</strong> Preserve cash by paying Director fees via equity issuance.  </p>\n<p><strong>Key Details:</strong><br />\n- Shares rank equally with existing securities.<br />\n- No underwriting, lead manager, or escrow restrictions.<br />\n- If Director departs before 31 March 2026, proportional cash repayment required.  </p>\n<p><em>Omitted: Routine legal terms, Director names, and non-material procedural details.</em></p>",
    "usage": {
      "prompt_tokens": 1923,
      "completion_tokens": 185,
      "total_tokens": 2108,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-16T21:43:01.309722"
  }
]